What is Virax Biolabs Group Limited Ordinary Shares?
Virax Biolabs Group Limited, a biotechnology company, focuses on immune response detection, T cell immune profiling, and the development of in vitro diagnostic technologies for viral and immune-mediated diseases in the United Kingdom, the United States, and China.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
Virax Biolabs Group Limited, a biotechnology company, focuses on immune response detection, T cell immune profiling, and the development of in vitro diagnostic technologies for viral and immune-mediated diseases in the United Kingdom, the United States, and China. The company offers ViraxImmune, a T cell-based immune profiling and diagnostic platform for post-acute infection syndromes, including long COVID, myalgic encephalomyelitis / chronic fatigue syndrome, and post-treatment Lyme disease. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 823.94K.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.